AI may make clinical supply forecasting faster, but cheaper tokens can drive higher costs. See how to measure AI at scale before a pilot becomes an expensive surprise.
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- What Will Life Science Orgs Do When The AI Bill Comes Through?
- Clinical Trial Standards — What They Are And Why They're Indispensable
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Advancing Patient-Centric Research With DHTs
Sleep quality is pivotal for overall health. Explore how wearable digital health technologies can revolutionize our understanding of sleep and enhance research outcomes.
-
Parkinson's Disease: Leveraging Wearable DHTs
Wearable DHTs offer a solution to the challenges of measuring Parkinson's disease in clinical trials. Discover how these technologies can improve outcome measures and accelerate drug development.
-
RTSM And Clinical Drug Dispensation
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
Immuno-Inflammation Clinical Trials: Challenges And Solutions
Learn why having a strong and robust eCOA solution, along with an understanding of the specific challenges of this therapeutic area, is critical to the success of immuno-inflammation clinical trials.
-
How Automated Site Payment Solutions Are Revolutionizing Clinical Trials
Discover how a specialized site payment solution can streamline your clinical trials, enhance site engagement, and deliver measurable financial benefits.
-
Frequently Asked Questions About Travel For Clinical Trial Patients
Find answers to the most common questions about trial travel support, from booking rides to arranging complex logistics for caregivers and patients.
-
Vendor Selection Bias: Why Structured Decisions Often Fail
Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
-
eConsent For Clinical Trials: Frequently Asked Questions (FAQ)
Got questions about eConsent? Here we break down how digital consent works, why it beats paper, and how it helps sites, sponsors, and participants across the trial lifecycle.
-
eCOA Evolution: Have We Overcomplicated It?
eCOA has evolved from simple data collection to complex patient engagement platforms, raising concerns about added complexity. Explore innovative tools aimed at simplifying this complexity.
-
How Paper And Electronic Source Data Meet ALCOA-C Principles
According to the Food and Drug Administration (FDA), data should meet certain fundamental elements of quality. If these best practices for source documentation aren’t followed, there is no valid evidence the test article is safe and effective.
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
RECENT NEWSLETTERS
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality